Innovating
to meet real needs

We’re applying our expertise to innovate in the field of wellness and healthcare.

We are doing this through the development and commercialization of a pipeline of scalable products and brands, with the goal of supporting healthier lifestyles and addressing unmet needs.

Consumer health

Cannabinoids

Inhaled therapeutics

Nicotine replacement therapy

Consumer health

We are passionate about finding new and better ways to improve lives by building healthier futures.

To succeed in this space, we’re taking a partnership approach. In tandem with our proprietary innovations and industry expertise, we’re teaming up with companies with existing sales and marketing capabilities to rapidly co-develop and co-commercialize each innovation.

 

“Our initial focus is on the ‘Purposeful Energy’ segment of the market, offering consumers healthier, holistic and engaging solutions to purposefully enhance their physical and mental energy levels.”
Kim Binderup
Kim Binderup
Chief Consumer Health Officer

Cannabinoids

Our ambition is to be a leader in developing and commercializing safe, effective, and best-in-class medical and non-recreational wellness cannabinoid products (including CBD) that patients and consumers can trust.

We apply rigorous scientific standards, and patient and consumer insights, and have the capabilities to responsibly lead the way, with a unique combination of innovative technologies and prescription drug development expertise.

We believe our approach can unlock the potential of cannabinoids to address unmet medical and health needs, while meeting the potential requirements of a complex legal and regulatory environment. All rooted in robust clinical product development and scientific principles.

“We believe that cannabinoids have a role to play in wellness and healthcare. But there is a need for science-backed products and standards for safety, dose and quality.”
Julia Hoeng
Julia Hoeng
Vice President, Innovation & Product
Development (Cannabinoids)

Inhaled therapeutics

We currently have products in development that have the potential to optimize formulas and provide new treatments for pain management.

“We are developing products that have the potential to provide new treatments across a range of clinical indications.”
Dr Thomas Blaettler
Dr Thomas Blaettler
Chief Medical Officer
“We are developing products that have the potential to provide new treatments across a range of clinical indications.”
Dr Thomas Blaettler
Dr Thomas Blaettler
Chief Medical Officer

Nicotine replacement therapy (NRT)

For decades, NRT products have been important tools for adult smokers trying to quit smoking.

As regulated pharmaceutical products, they have a single active ingredient – nicotine – and are clinically proven to help change behaviors and support smoking-cessation. 1 2

At Aspeya, we are developing innovative NRT formats that are more efficacious and easier to fit into existing routines.

Please note: Availability of these products may vary by country, and in some jurisdictions, a prescription may be required. Always check local regulations or discuss with a doctor.
1Wadgave U, Nagesh L. Nicotine Replacement Therapy: An Overview. Int J Health Sci (Qassim). 2016 Jul;10(3):425-35. PMID: 27610066; PMCID: PMC5003586.
2https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000146.pub5/full
“We are developing effective, innovative and user-friendly NRT formats to support adult smokers in their smoking cessation journeys.”
Joel Rubenstein
Joel Rubenstein
Category Head, Nicotine Replacement Therapy